BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8993332)

  • 1. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide.
    Krishnaswamy S; Vlasuk GP; Bergum PW
    Biochemistry; 1994 Jun; 33(25):7897-907. PubMed ID: 8011652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosites determine macromolecular substrate recognition by prothrombinase.
    Krishnaswamy S; Betz A
    Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
    Rezaie AR
    Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles.
    Krishnaswamy S; Jones KC; Mann KG
    J Biol Chem; 1988 Mar; 263(8):3823-34. PubMed ID: 3346225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.
    Buddai SK; Toulokhonova L; Bergum PW; Vlasuk GP; Krishnaswamy S
    J Biol Chem; 2002 Jul; 277(29):26689-98. PubMed ID: 12011050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of factor Va on the active site of factor Xa.
    Walker RK; Krishnaswamy S
    J Biol Chem; 1993 Jul; 268(19):13920-9. PubMed ID: 8314758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
    Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
    Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.
    Boskovic DS; Krishnaswamy S
    J Biol Chem; 2000 Dec; 275(49):38561-70. PubMed ID: 10984491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation.
    Krishnaswamy S
    J Biol Chem; 1990 Mar; 265(7):3708-18. PubMed ID: 2303476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.